THERAPY WITH JAK INHIBITORS AND THE RISK OF CARDIOVASCULAR EVENTS IN A DUTCH RHEUMATOID ARTHRITIS POPULATION

被引：0
|
作者：
Popa, C. [1 ,2 ]
Opdam, M. [1 ]
Den Broeder, N. [1 ]
Wientjes, M. [1 ]
Den Broeder, A. [1 ,2 ]
机构：
[1] Sint Maartensklin, Rheumatol, Ubbergen, Netherlands
[2] Radboudumc, Rheumatol, Nijmegen, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Cardiovascular disease; Targeted synthetic; drugs;
D O I：
10.1136/annrheumdis-2023-eular.4033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0221
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [41] Evaluation of Treatment Discontinuation Due to Adverse Events, and the Effect of Cardiovascular Risk Factors or Type of JAK-inhibitors: An International Collaboration of Registries of Rheumatoid Arthritis Patients (the
    Lauper, Kim
    Aymon, Romain
    Mongin, Denis
    Bergstra, Sytske Anne
    Choquette, Denis
    Codreanu, Catalin
    Elkayam, Ori
    Hyrich, Kimme
    Iannone, Florenzo
    Inanc, Nevsun
    Kearsley-Fleet, Lianne
    Kvien, Tore K.
    Kristianslund, Eirik
    Leeb, Burkhard
    Lukina, Galina
    Nordstrom, Dan
    Pavelka, Karel
    Pombo-Suarez, Manuel
    Rotar, Ziga
    Santos, Maria Jose
    Courvoisier, Delphine
    Finckh, Axel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 558 - 561
  • [42] Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
    Scott, Ian C.
    Hider, Samantha L.
    Scott, David L.
    DRUG SAFETY, 2018, 41 (07) : 645 - 653
  • [43] Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study
    Meng, Huan
    Lam, Steven H.
    So, Ho
    Tam, Lai -Shan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 65
  • [44] Risk Of Cardiovascular Events In Patients With Psoriatic Arthritis, Psoriasis, and Rheumatoid Arthritis: A General Population-Based Cohort Study
    Ogdie, Alexis
    Yu, Yiding
    Haynes, Kevin
    Maliha, Samantha
    Love, Thorvardur
    Troxel, Andrea
    Hennessy, Sean
    Margolis, David
    Kimmel, Stephen
    Mehta, Nehal N.
    Choi, Hyon K.
    Gelfand, Joel
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S128 - S128
  • [45] Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
    Ogdie, Alexis
    Yu, YiDing
    Haynes, Kevin
    Love, Thorvardur Jon
    Maliha, Samantha
    Jiang, Yihui
    Troxel, Andrea B.
    Hennessy, Sean
    Kimmel, Steven E.
    Margolis, David J.
    Choi, Hyon
    Mehta, Nehal N.
    Gelfand, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 326 - 332
  • [46] CARDIOVASCULAR EVENTS AND RHEUMATOID ARTHRITIS IN LATVIA
    Stumberga, E. Stumbra
    Stukena, I.
    Els, R.
    Baltgaile, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 642 - 642
  • [47] Rheumatoid arthritis and the incidence of cardiovascular events
    Compton, P. A.
    Banerjee, S.
    Cipher, D.
    Hooker, R.
    Kazi, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 347 - 348
  • [48] Systematic Review of the Effect of TNFα-inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis
    Sattin, Michael
    Towheed, Tanveer
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1322 - 1322
  • [49] A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease
    Cronin, Owen
    McKnight, Olivia
    Keir, Lindsay
    Ralston, Stuart H.
    Hirani, Nikhil
    Harris, Helen
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (05) : 921 - 928
  • [50] Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors
    Atzeni, Fabiola
    Talotta, Rossella
    Nucera, Valeria
    Marino, Francesca
    Gerratana, Elisabetta
    Sangari, Donatella
    Masala, Ignazio Francesco
    Sarzi-Puttini, Piercarlo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (11) : 945 - 956
12345